Literature DB >> 25894404

Conservative Treatment in Selected Patients with Severe Critical Limb Ischemia.

Adriaan R Thomas1, Jelle W Raats, Mare M A Lensvelt, Hans G W de Groot, Eelco J Veen, Lijckle van der Laan.   

Abstract

OBJECTIVE: To assess the outcome of conservative treatment of severe critical limb ischemia (CLI) classified as Rutherford 5/6.
BACKGROUND: The preferred therapy for CLI is either endovascular revascularization or bypass surgery. With a growing aged population with more serious comorbidities, these therapies are not always a viable option. Primary amputation leads to decreased mobility and a reduced quality of life. There is a lack of literature regarding the outcome of conservative therapy.
METHODS: Hospital charts were reviewed of all patients who were diagnosed with Rutherford classification 5-6 and received conservative treatment and lacked interventional options. Outcome measures were mortality, complete wound closure, and limb salvage rate.
RESULTS: 38 patients were included with a median age of 80 years (range 57-97). The amputation rate during follow-up was 16%. In 58% of patients, complete wound closure was achieved. All-cause mortality was 58% with a 2-year survivability rate of 55%.
CONCLUSIONS: Conservative management in our selected patients with CLI results in a moderate rate of wound closure and acceptable amputation rates albeit with a high mortality rate. For patients not eligible for endovascular revascularization or bypass surgery, conservative treatment could be a viable option besides primary limb amputation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25894404     DOI: 10.1007/s00268-015-3069-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  14 in total

Review 1.  Medical treatment of peripheral arterial disease and claudication.

Authors:  W R Hiatt
Journal:  N Engl J Med       Date:  2001-05-24       Impact factor: 91.245

2.  Is revascularization and limb salvage always the best treatment for critical limb ischemia?

Authors:  Mark R Nehler; William R Hiatt; Lloyd M Taylor
Journal:  J Vasc Surg       Date:  2003-03       Impact factor: 4.268

3.  Vascular disease of the heart, brain and limbs: new insights into a looming epidemic.

Authors:  Graeme J Hankey
Journal:  Lancet       Date:  2005-11-19       Impact factor: 79.321

4.  Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial.

Authors:  D J Adam; J D Beard; T Cleveland; J Bell; A W Bradbury; J F Forbes; F G R Fowkes; I Gillepsie; C V Ruckley; G Raab; H Storkey
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

5.  The ASA classification and peri-operative risk.

Authors:  Jo Fitz-Henry
Journal:  Ann R Coll Surg Engl       Date:  2011-04       Impact factor: 1.891

6.  Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization.

Authors:  William A Marston; Stephen W Davies; Brian Armstrong; Mark A Farber; Robert C Mendes; Joseph J Fulton; Blair A Keagy
Journal:  J Vasc Surg       Date:  2006-07       Impact factor: 4.268

7.  Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials.

Authors:  Martin Teraa; Ralf W Sprengers; Yolanda van der Graaf; Charmaine E J Peters; Frans L Moll; Marianne C Verhaar
Journal:  Ann Surg       Date:  2013-12       Impact factor: 12.969

8.  A study of biofilm-based wound management in subjects with critical limb ischaemia.

Authors:  R D Wolcott; D D Rhoads
Journal:  J Wound Care       Date:  2008-04       Impact factor: 2.072

Review 9.  Systematic review on health-related quality of life after revascularization and primary amputation in patients with critical limb ischemia.

Authors:  Jan Bosma; Anco Vahl; Willem Wisselink
Journal:  Ann Vasc Surg       Date:  2013-08-26       Impact factor: 1.466

10.  Outcome of unreconstructed chronic critical leg ischaemia.

Authors:  M Lepäntalo; S Mätzke
Journal:  Eur J Vasc Endovasc Surg       Date:  1996-02       Impact factor: 7.069

View more
  5 in total

1.  Critical Limb Ischemia in Nonagenarians: A Challenge of Our Times.

Authors:  Eduard Casajuana Urgell; Laura Calsina Juscafresa; Lluis Nieto Fernandez; Lorena Romero Montaña; Carme Llort Pont; Albert Clarà Velasco
Journal:  World J Surg       Date:  2022-05-04       Impact factor: 3.282

2.  Systematic review of pharmacological therapies for the management of ischaemic pain in patients with non-reconstructable critical limb ischaemia.

Authors:  Áine Ní Laoire; Fliss E M Murtagh
Journal:  BMJ Support Palliat Care       Date:  2017-08-23       Impact factor: 3.568

3.  Two-year Outcome of Quality of Life and Health Status for the Elderly with Chronic Limb-threatening Ischemia.

Authors:  Chloé M L Peters; Paul Lodder; Jolanda de Vries; Stijn L Steunenberg; Eelco J Veen; Hans G W de Groot; Gwan H Ho; Lijckle van der Laan
Journal:  Clin Interv Aging       Date:  2020-12-22       Impact factor: 4.458

4.  Revascularization Techniques for Limb Salvage in Critical Limb Ischemia: A Single Institutional Study From Pakistan.

Authors:  Tehreem Kazmi; Faiza H Soomro; Mehwish Ansar
Journal:  Cureus       Date:  2022-08-11

5.  Important differences between quality of life and health status in elderly patients suffering from critical limb ischemia.

Authors:  Stijn L Steunenberg; Jolanda de Vries; Jelle W Raats; Nathalie Verbogt; Paul Lodder; Geert-Jan van Eijck; Eelco J Veen; Hans Gw de Groot; Gwan H Ho; Lijckle van der Laan
Journal:  Clin Interv Aging       Date:  2019-07-08       Impact factor: 4.458

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.